NCT03242096 is a NA clinical trial of Sirolimus coated balloon in Coronary Restenosis, sponsored by InnoRa GmbH.

Who is sponsoring NCT03242096?

NCT03242096 is sponsored by InnoRa GmbH.

What drugs are being tested in NCT03242096?

Interventions in NCT03242096: Sirolimus coated balloon, Paclitaxel coated balloon.

What condition does NCT03242096 study?

NCT03242096 studies Coronary Restenosis.

Is NCT03242096 still recruiting?

NCT03242096 is currently completed. Last updated 27 August 2021.

Last reviewed 2021-08-27 · How we verify

NCT03242096

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Completed NA Last updated 27 August 2021

What this trial tests

NA trial testing Sirolimus coated balloon in Coronary Restenosis in 50 participants. Completed in 31 January 2021.

Timeline

21 July 2017

Primary endpoint
1 August 2020

31 January 2021

Quick facts

Lead sponsor	InnoRa GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	21 July 2017
Primary completion	1 August 2020
Estimated completion	31 January 2021
Sites	5 locations across Switzerland, Germany

Drugs / interventions tested

Sirolimus coated balloon
Paclitaxel coated balloon

Conditions studied

Coronary Restenosis — all drugs for Coronary Restenosis →

Sponsor

InnoRa GmbH

Who can join

18 and older, any sex, with Coronary Restenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatment of coronary in-stent restenosis (ISR) by a sirolimus coated SEQUENT® SCB RAPID EXCHANGE PTCA balloon catheter or a paclitaxel coated SEQUENT® PLEASE PTCA balloon catheter

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.
Scheller B, Mangner N, Abdul Kader MASK, Wan Ahmad WA, et al · · 2022 · cited 44× · PMID 36126132 · DOI 10.1161/circinterventions.122.012305
Intrastent Restenosis: A Comprehensive Review.
Bajeu IT, Niculescu AG, Scafa-Udriște A, Andronescu E. · · 2024 · cited 18× · PMID 38338993 · DOI 10.3390/ijms25031715

Verify or expand the search:

Other trials of Sirolimus coated balloon

Trials testing the same drug.

NCT02996318 — Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon · NA · completed

Other recruiting trials for Coronary Restenosis

Currently open trials in the same condition.

NCT06075602 — COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLE · recruiting
NCT04988685 — SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With · recruiting

Other InnoRa GmbH trials

Trials by the same sponsor.

NCT05445258 — Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon · NA · terminated
NCT03908450 — Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter · NA · completed
NCT04017364 — Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter Malaysia · NA · completed
NCT03332264 — Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions · NA · completed
NCT02996318 — Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03242096 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by InnoRa GmbH
Last refreshed: 27 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03242096.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing